These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7496088)

  • 21. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of granulocyte colony-stimulating factor after intensive induction therapy in relapsed or refractory acute leukemia.
    Ohno R; Tomonaga M; Kobayashi T; Kanamaru A; Shirakawa S; Masaoka T; Omine M; Oh H; Nomura T; Sakai Y
    N Engl J Med; 1990 Sep; 323(13):871-7. PubMed ID: 1697646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease.
    Notario A; Rolandi ML; Mazzucchelli I
    Haematologica; 1996; 81(3):261-4. PubMed ID: 8767533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. G-CSF-induced remission in two cases of acute myeloid leukemia.
    Benz R; Goede JS; Parlier V; Mühlematter D; Jotterand M; Fehr J
    Leuk Res; 2008 Jul; 32(7):1148-52. PubMed ID: 18166225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
    Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
    Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor priming regimen on patients with advanced myelodysplastic syndrome or acute myeloid leukemia transformed from myelodysplastic syndrome.
    Wu L; Li X; Su J; Chang C; He Q; Zhang X; Xu L; Song L; Pu Q
    Leuk Lymphoma; 2009 Sep; 50(9):1461-7. PubMed ID: 19672772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human granulocyte colony-stimulating factor in combination with continuous infusion of cytosine arabinoside for the treatment of refractory acute myelogenous leukemia.
    Goto H; Shimazaki C; Hirata T; Ashihara E; Ohkawa K; Oku N; Inaba T; Fujita N; Nakagawa M
    Acta Haematol; 1993; 89(3):144-8. PubMed ID: 7689779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-dose cytarabine and recombinant human granulocyte colony-stimulating factor for the treatment of resistant acute myelogenous leukemia.
    Schiller G; Emmanoulides C; Iastrebner MC; Lee M; Naeim F
    Leuk Lymphoma; 1996 Feb; 20(5-6):427-34. PubMed ID: 8833398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination chemotherapy with G-CSF, M-CSF and EPO: successful treatment for acute myelogenous leukemia without blood transfusion at lower medical costs.
    Kaito K; Kobayashi M; Sakamoto M; Shimada T; Masuoka H; Nishiwaki K; Saeki A; Sekita T; Otsubo H; Hosoya T
    Acta Haematol; 1998; 100(1):57-60. PubMed ID: 9691149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed-onset effect of clofarabine in the treatment of an adult patient with acute myeloid leukemia.
    Walchack R; Cumpston A; Vos J; Kanate AS
    Am J Health Syst Pharm; 2019 Feb; 76(6):349-352. PubMed ID: 31361841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of granulocyte colony-stimulating factor in the treatment of acute myelogenous leukaemia: a multicentre randomized study.
    Usuki K; Urabe A; Masaoka T; Ohno R; Mizoguchi H; Hamajima N; Miyazaki T; Niitsu Y; Yoshida Y; Miura A; Shibata A; Abe T; Miura Y; Ikeda Y; Nomura T; Nagao T; Saitou H; Shirakawa S; Ohkuma M; Matsuda T; Nakamura T; Horiuchi A; Kuramoto A; Kimura I; Irino S; Niho Y; Takatsuki K; Tomonaga M; Uchino H; Takaku F;
    Br J Haematol; 2002 Jan; 116(1):103-12. PubMed ID: 11841402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete remission in three patients with acute myeloblastic leukemia by administration of G-CSF without antileukemic agents.
    Takahashi M; Koike T; Aizawa Y; Kashimura M; Hayatsu K; Nagai K; Abe A; Urushiyama M; Yagisawa K
    Am J Hematol; 1997 Sep; 56(1):42-4. PubMed ID: 9298867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Complete remission during administration of rhG-CSF in acute myeloblastic leukemia with pneumonia].
    Hayatsu K; Nagai K; Abe A; Murakawa E; Sekiya M
    Rinsho Ketsueki; 1994 Jan; 35(1):59-64. PubMed ID: 7511179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of acute myeloblastic leukaemia in a case of aplastic anaemia treated with granulocyte colony-stimulating factor.
    Izumi T; Muroi K; Takatoku M; Imagawa S; Hatake K; Miura Y
    Br J Haematol; 1994 Jul; 87(3):666-8. PubMed ID: 7527651
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Granulocyte colony-stimulating factor following chemotherapy in elderly patients with newly diagnosed acute myelogenous leukemia.
    Maslak PG; Weiss MA; Berman E; Yao TJ; Tyson D; Golde DW; Scheinberg DA
    Leukemia; 1996 Jan; 10(1):32-9. PubMed ID: 8558934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of priming with granulocyte colony-stimulating factor on the outcome of chemotherapy for acute myeloid leukemia.
    Löwenberg B; van Putten W; Theobald M; Gmür J; Verdonck L; Sonneveld P; Fey M; Schouten H; de Greef G; Ferrant A; Kovacsovics T; Gratwohl A; Daenen S; Huijgens P; Boogaerts M; ;
    N Engl J Med; 2003 Aug; 349(8):743-52. PubMed ID: 12930926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone marrow morphology during induction phase of therapy for acute myeloid leukemia (AML).
    Dick FR; Burns CP; Weiner GJ; Heckman KD
    Hematol Pathol; 1995; 9(2):95-106. PubMed ID: 7559259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of cytokines in the treatment of acute myelocytic leukemia: a critical review.
    Geller RB
    J Clin Oncol; 1996 Apr; 14(4):1371-82. PubMed ID: 8648396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of granulocyte colony-stimulating factor on outcomes in patients with non-M3 acute myelogenous leukemia treated with anthracycline-based induction (7+3 regimen) chemotherapies.
    Kang KW; Kim DS; Lee SR; Sung HJ; Kim SJ; Choi CW; Kim BS; Park Y
    Leuk Res; 2017 Jun; 57():1-8. PubMed ID: 28231491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Complete remission induced by combined treatment with all-trans retinoic acid (ATRA) and granulocyte colony-stimulating factor (G-CSF) in a patient with relapsed acute promyelocytic leukemia].
    Wakayama T; Furuya H; Takagi C; Ichiba S; Kato Y
    Rinsho Ketsueki; 1994 Nov; 35(11):1315-21. PubMed ID: 7529843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.